50-112-9760

CD56 (NCAM) Monoclonal Antibody (TULY56), eFluor™ 450, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-112-9760-Each-of-1 In Stock ₹ 25,632.00

50-112-9760 - Each of 1

₹ 25,632.00

In Stock

Quantity

1

Base Price: ₹ 25,632.00

GST (18%): ₹ 4,613.76

Total Price: ₹ 30,245.76

Antigen

CD56 (NCAM)

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

P13591

Gene Symbols

Ncam1

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

4684, 693789

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

TULY56

Conjugate

eFluor 450

Gene

Ncam1

Gene Alias

adhesion molecule; antigen recognized by monoclonal antibody 5.1H11; Cd56; CD-56; CD56 120 kDa GPI-linked isoform; CD56 140 kDa isoform; CD56 140 kDa VASE isoform; E NCAM; E-NCAM; MSK39; N CAM1; NCAM; N-CAM; Ncam1; N-CAM-1; NCAM-1; NCAMC; NCAM-C; neural cell adhesion molecule; Neural cell adhesion molecule 1; neural cell adhesion molecule, NCAM; sCD56; sNCAM; soluble CD56; soluble NCAM

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human, Non-human Primate, Rhesus Monkey

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

50-112-4956

--

Img

Invitrogen

25-056-642

--

Img

Invitrogen

50-112-4769

--

Img

Invitrogen

15-056-642

--

Img

Invitrogen

25-106-941

--

Img

Invitrogen

14-106-937

--

Img

Invitrogen

50-112-8866

--

Img

Invitrogen

50-112-8736

--

Description

  • Description: This TULY56 monoclonal antibody reacts with human CD56, also known as Neural Cell Adhesion Molecule (NCAM)
  • CD56 is a highly glycosylated transmembrane molecule expressed by neurons and plays a role in the homotypic adhesion of neural cells
  • In the hematopoietic system, CD56 is expressed on NK cells and a subset of T cells referred to as NKT cells
  • Staining with TULY56 does not block binding of CMSSB, suggesting that the two antibodies recognize different epitopes
  • Additionally, TULY56 performs better after fixation and permeabilization than CMSSB
  • The TULY56 monoclonal antibody crossreacts with Rhesus macaque
  • Applications Reported: This TULY56 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This TULY56 antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells
  • This can be used at 5 μL (0.125 μg) per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • eFluor™ 450 is an alternative to Pacific Blue™
  • eFluor™ 450 emits at 445 nm and is excited with the Violet laser (405 nm)
  • Please make sure that your instrument is capable of detecting this fluorochome
  • Excitation: 405 nm; Emission: 445 nm; Laser: Violet Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • CD56 (NCAM, neural cell adhesion molecule) is a transmembrane glycoprotein of the immunoglobulin family that serves as an adhesive molecule and is ubiquitously expressed in the nervous system in isoforms ranging from 120-180 kDa
  • CD56 is found on T cells and NK cells, and is involved in cell migration, axonal growth, pathfinding and synaptic plasticity
  • Polysialic modification results in reduction of CD56-mediated cell adhesion
  • Through its extracellular region, CD56 mediates homophilic and heterophilic interactions by binding extracellular matrix components such as laminin and integrins
  • CD56 is expressed on most neuroectodermal derived cell lines, tissues and neoplasms such as retinoblastoma, medulloblastoma, astrocytomas and neuroblastoma
  • Further, CD56 is a widely used neuroendocrine marker with a high sensitivity for neuroendocrine tumors and ovarian granulosa cell tumors
  • Diseases associated with CD56 dysfunction include rabies and blastic plasmacytoid dendritic cell neoplasms.